JP2013533210A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013533210A5 JP2013533210A5 JP2013509186A JP2013509186A JP2013533210A5 JP 2013533210 A5 JP2013533210 A5 JP 2013533210A5 JP 2013509186 A JP2013509186 A JP 2013509186A JP 2013509186 A JP2013509186 A JP 2013509186A JP 2013533210 A5 JP2013533210 A5 JP 2013533210A5
- Authority
- JP
- Japan
- Prior art keywords
- monoclonal antibody
- amino acid
- administration
- use according
- deletion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33056810P | 2010-05-03 | 2010-05-03 | |
| US61/330,568 | 2010-05-03 | ||
| PCT/US2011/035033 WO2011140114A2 (en) | 2010-05-03 | 2011-05-03 | Anti-glucosaminidase passive immunization for staphylococcus aureus infections |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016214728A Division JP6227092B2 (ja) | 2010-05-03 | 2016-11-02 | 黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）感染のための抗グルコサミニダーゼ受動免疫化 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013533210A JP2013533210A (ja) | 2013-08-22 |
| JP2013533210A5 true JP2013533210A5 (enExample) | 2014-06-26 |
| JP6038777B2 JP6038777B2 (ja) | 2016-12-07 |
Family
ID=44904432
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013509186A Active JP6038777B2 (ja) | 2010-05-03 | 2011-05-03 | 黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）感染のための抗グルコサミニダーゼ受動免疫化 |
| JP2016214728A Active JP6227092B2 (ja) | 2010-05-03 | 2016-11-02 | 黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）感染のための抗グルコサミニダーゼ受動免疫化 |
| JP2017196867A Active JP6580649B2 (ja) | 2010-05-03 | 2017-10-10 | 黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）感染のための抗グルコサミニダーゼ受動免疫化 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016214728A Active JP6227092B2 (ja) | 2010-05-03 | 2016-11-02 | 黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）感染のための抗グルコサミニダーゼ受動免疫化 |
| JP2017196867A Active JP6580649B2 (ja) | 2010-05-03 | 2017-10-10 | 黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）感染のための抗グルコサミニダーゼ受動免疫化 |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US9737601B2 (enExample) |
| EP (2) | EP3150631B1 (enExample) |
| JP (3) | JP6038777B2 (enExample) |
| AU (1) | AU2011248209B2 (enExample) |
| CA (1) | CA2797121C (enExample) |
| ES (1) | ES2606017T3 (enExample) |
| WO (1) | WO2011140114A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6038777B2 (ja) | 2010-05-03 | 2016-12-07 | ユニバーシティー オブ ロチェスター | 黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）感染のための抗グルコサミニダーゼ受動免疫化 |
| AU2015224393B2 (en) * | 2011-11-02 | 2016-12-15 | University Of Rochester | Anti-glucosaminidase passive immunization for staphylococcus aureus infections |
| CA2853943C (en) * | 2011-11-02 | 2015-12-08 | University Of Rochester | Anti-glucosaminidase passive immunization for staphylococcus aureus infections |
| WO2014143886A2 (en) * | 2013-03-15 | 2014-09-18 | Edimer Pharmaceuticals, Inc. | Anti-ectodysplasin antibodies |
| BR112016013514B1 (pt) * | 2013-12-13 | 2022-04-19 | Stora Enso Oyj (Fi) | Papelão de múltiplas camadas |
| US10759859B2 (en) | 2016-01-14 | 2020-09-01 | Bps Bioscience, Inc. | Anti-PD-1 antibodies and uses thereof |
| EP3580241A4 (en) | 2017-02-10 | 2021-01-06 | The Trustees Of The University Of Pennsylvania | ANTI-FACTOR D ANTIBODIES AND USES OF THESE LATEST |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| CA3204730A1 (en) * | 2021-01-15 | 2022-07-21 | Gowrishankar MUTHUKRISHNAN | Staphylococcus aureus antigen-based nucleic acid vaccines |
| AU2022220314A1 (en) * | 2021-02-12 | 2023-09-14 | Telephus Biosciences, Llc | Antibodies that bind glucosaminidase and uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4237224A (en) | 1974-11-04 | 1980-12-02 | Board Of Trustees Of The Leland Stanford Jr. University | Process for producing biologically functional molecular chimeras |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5750373A (en) | 1990-12-03 | 1998-05-12 | Genentech, Inc. | Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| AU8507191A (en) | 1990-08-29 | 1992-03-30 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5516637A (en) | 1994-06-10 | 1996-05-14 | Dade International Inc. | Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage |
| US6228619B1 (en) | 1996-02-20 | 2001-05-08 | Smithkline Beecham Corporation | Glucosaminidase |
| US8735554B2 (en) * | 2008-05-07 | 2014-05-27 | Innovative Biosensors, Inc. | Reagents, methods, and systems for detecting methicillin-resistant Staphylococcus |
| US8697375B2 (en) * | 2008-09-02 | 2014-04-15 | University Of Maryland, Baltimore | In vivo biofilm infection diagnosis and treatment |
| EP2344189B1 (en) * | 2008-09-30 | 2018-05-30 | University of Maryland, Baltimore | Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens |
| JP6038777B2 (ja) | 2010-05-03 | 2016-12-07 | ユニバーシティー オブ ロチェスター | 黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）感染のための抗グルコサミニダーゼ受動免疫化 |
-
2011
- 2011-05-03 JP JP2013509186A patent/JP6038777B2/ja active Active
- 2011-05-03 CA CA2797121A patent/CA2797121C/en active Active
- 2011-05-03 EP EP16187268.4A patent/EP3150631B1/en active Active
- 2011-05-03 AU AU2011248209A patent/AU2011248209B2/en active Active
- 2011-05-03 WO PCT/US2011/035033 patent/WO2011140114A2/en not_active Ceased
- 2011-05-03 EP EP11778188.0A patent/EP2566891B1/en active Active
- 2011-05-03 ES ES11778188.0T patent/ES2606017T3/es active Active
- 2011-05-03 US US13/696,019 patent/US9737601B2/en active Active
-
2016
- 2016-11-02 JP JP2016214728A patent/JP6227092B2/ja active Active
-
2017
- 2017-07-28 US US15/662,715 patent/US10179170B2/en active Active
- 2017-10-10 JP JP2017196867A patent/JP6580649B2/ja active Active
-
2018
- 2018-12-14 US US16/221,442 patent/US10653775B2/en active Active
-
2020
- 2020-05-01 US US16/864,343 patent/US11065333B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013533210A5 (enExample) | ||
| Whiteside et al. | One-stage revision with catheter infusion of intraarticular antibiotics successfully treats infected THA | |
| Hake et al. | Local antibiotic therapy strategies in orthopaedic trauma: practical tips and tricks and review of the literature | |
| Gitelis et al. | The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant | |
| JP2017504586A5 (enExample) | ||
| Wolford et al. | Management of the infected temporomandibular joint total joint prosthesis | |
| Herford et al. | Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2) | |
| Zheng et al. | The use of BMP-2 coupled–Nanosilver-PLGA composite grafts to induce bone repair in grossly infected segmental defects | |
| Qiang et al. | Use of antibiotic cement rod to treat intramedullary infection after nailing: preliminary study in 19 patients | |
| CA2797121A1 (en) | Anti-glucosaminidase passive immunization for staphylococcus aureus infections | |
| Matic et al. | A contraindication for the use of hydroxyapatite cement in the pediatric population | |
| Bhatia et al. | Role of antibiotic cement coated nailing in infected nonunion of tibia | |
| Neumann et al. | Two-stage cementless revision of late total hip arthroplasty infection using a premanufactured spacer | |
| Barger et al. | Antibiotic-coated interlocking intramedullary nail for the treatment of long-bone osteomyelitis | |
| Bhattacharya et al. | Systematic approach to treat chronic osteomyelitis through localized drug delivery system: bench to bed side | |
| ES3041577T3 (en) | Compositions comrising an opioid growth factor receptor (ogfr) antagonist for use in promoting bone formation and in the treatment of cancer. | |
| HUP0303013A2 (hu) | Gyógyszer csontelhalás kezelésére és olyan betegek gondozására, akiknél a csontelhalás kialakulásának kockázata áll fenn | |
| ES2633978T3 (es) | Espaciador de articulaciones articulado de dos piezas y procedimiento para su fabricación | |
| WO2008033221A2 (en) | Therapeutic bone replacement material | |
| Mulcahy | Current approach to the treatment of penile implant infections | |
| Iyer et al. | Structural & functional rehabilitation in eyes with lamina resorption following MOOKP—can the lamina be salvaged? | |
| Ebied et al. | A protocol for staged arthroplasty to salvage infected nonunion of hip fractures | |
| Mulcahy | Penile implant infections: Prevention and treatment | |
| Jokhio et al. | Antibiotic Cement Coated Nailing in Infected Nonunion of Tibia | |
| Casap et al. | Imperforate titanium shell enclosing recombinant human bone morphogenetic protein-2–induced bone formation for high-profile dental implants in rabbit tibia |